Breakout Stocks of Week 16
NASDAQ was up last week (week 15) by 3.12% ending at 13,900.19 points after gaining 420.08 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Goldiam International Limited NSE:GOLDIAM. This stock has had a buy signal since Apr 08, 2021 when the price was ₹368.95 and is so far up 2.03% to ₹376.45. Some other companies are on our watchlist to, among these are Korn/Ferry International NYSE:KFY J. B. Chemicals & Pharmaceuticals Limited NSE:JBCHEPHARM Chiyoda Corporation FRA:CYA and Prospect Capital Corporation NASDAQ:PSEC which all got a breakout pattern emerging.
| Date | Company | Price | Week 16 |
|---|---|---|---|
| Goldiam International Limited | ₹376.45 | ₹338.90 | -9.97% |
| Korn/ferry International | $65.98 | $64.97 | -1.53% |
| J. B. Chemicals & Pharmaceuticals Limited | ₹1,264.45 | ₹1,221.10 | -3.43% |
| Chiyoda Corporation | 4.02€ | 3.92€ | -2.49% |
| Prospect Capital Corporation | $8.00 | $8.05 | 0.625% |
The Goldiam International Limited stock price gained 2.03% on the last trading day (Friday, 9th Apr 2021), rising from ₹368.95 to ₹376.45. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 6.72% from a day low at ₹369.00 to a day high of ₹393.80. The price has risen in 7 of the last 10 days and is up by 15.25% over the past 2 weeks. Volume fell on the last day by -323 thousand shares and in total, 277 thousand shares were bought and sold for approximately ₹104.45 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Goldiam International Limited holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
About Goldiam International Limited:
Goldiam International Limited manufactures and sells diamond studded gold and silver jewelry in India. The company operates in two segments, Jewellery Manufacturing Activity and Investment Activity. Its products include engagement rings, wedding bands, anniversary rings, bridal sets, earrings, pendants, and necklaces. The company also exports its products to the United States, Europe, and other countries. Goldiam International Limited was incorporated in 1986 and is headquartered in Mumbai, India.
The Korn/Ferry International stock price gained 2.53% on the last trading day (Friday, 9th Apr 2021), rising from $64.35 to $65.98. During the last trading day the stock fluctuated 4.08% from a day low at $63.46 to a day high of $66.05. The price has risen in 7 of the last 10 days and is up by 8.15% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 77 thousand more shares were traded than the day before. In total, 408 thousand shares were bought and sold for approximately $26.92 million.
On Feb 29, 2024, it was reported that William Blair gave KFY a "Outperform" grade with a "upgrade" action.
Korn/Ferry International holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
About Korn/Ferry International:
Korn Ferry, together with its subsidiaries, provides organizational consulting services worldwide. It operates through four segments: Consulting, Digital, Executive Search, and Recruitment Process Outsourcing (RPO) & Professional Search. The company provides executive search services to recruit board level, chief executive, other senior executive, and general management talent of organizations. It also offers organizational strategy, assessment and succession, leadership and professional development, and total reward services. In addition, the company provides RPO, business project, professional search, and outsource recruiting solutions. Further, the company offers tech-enabled solutions that identify structures, roles, capabilities, and behaviors to drive businesses. It serves public and private companies, and middle market and emerging growth companies, as well as government and non-profit organizations. The company was formerly known as Korn/Ferry International and changed its name to Korn Ferry in January 2019. Korn Ferry was founded in 1969 and is based in Los Angeles, California.
J. B. Chemicals & Pharmaceuticals Limited
NSE:JBCHEPHARM
The J. B. Chemicals & Pharmaceuticals Ltd stock price gained 1.58% on the last trading day (Friday, 9th Apr 2021), rising from ₹1,244.80 to ₹1,264.45. During the last trading day the stock fluctuated 1.52% from a day low at ₹1,249.95 to a day high of ₹1,269.00. The price has been going up and down for this period, and there has been a 2.65% gain for the last 2 weeks. Volume fell on the last day by -2 billion shares and in total, 19 thousand shares were bought and sold for approximately ₹24.63 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
J. B. Chemicals & Pharmaceuticals Ltd holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
About J. B. Chemicals & Pharmaceuticals Limited:
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. The company manufactures a range of specialty products that include various pharmaceutical dosage forms. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and medicated and herbal lozenges. The company was incorporated in 1976 and is headquartered in Mumbai, India.
The Chiyoda Corporation stock price gained 2.03% on the last trading day (Friday, 9th Apr 2021), rising from 3.94€ to 4.02€. During the last trading day the stock fluctuated 0% from a day low at 4.02€ to a day high of 4.02€. The price has risen in 7 of the last 10 days and is up by 17.54% over the past 2 weeks.
Chiyoda Corporation holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
About Chiyoda Corporation:
Chiyoda Corporation operates as an integrated engineering company in Japan and internationally. It offers consulting, planning, engineering, procurement, construction, commissioning, and maintenance services for facilities related to gas, electricity, petroleum, petrochemical, chemical, pharmaceutical, antipollution, environment, preservation, and others. The company also explores for oil, gas, and other mineral resources, as well as invests in and finances exploration activities. Chiyoda Corporation was incorporated in 1948 and is headquartered in Yokohama, Japan.
The Prospect Capital Corporation stock price gained 0.251% on the last trading day (Friday, 9th Apr 2021), rising from $7.98 to $8.00. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 1.01% from a day low at $7.96 to a day high of $8.04. The price has risen in 8 of the last 10 days and is up by 3.9% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 457 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $16.91 million.
Prospect Capital Corporation holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
About Prospect Capital Corporation:
Prospect Capital Corporation is a business development company. It specializes in middle market, mature, mezzanine finance, later stage, emerging growth, leveraged buyouts, refinancing, acquisitions, recapitalizations, turnaround, growth capital, development, capital expenditures and subordinated debt tranches of collateralized loan obligations, cash flow term loans, market place lending and bridge transactions. It also makes real estate investments particularly in multi-family residential real estate asset class. The fund makes secured debt, senior debt, senior and secured term loans, unitranche debt, first-lien and second lien, private debt, private equity, mezzanine debt, and equity investments in private and microcap public businesses. It focuses on both primary origination and secondary loans/portfolios and invests in situations like debt financings for private equity sponsors, acquisitions, dividend recapitalizations, growth financings, bridge loans, cash flow term loans, real estate financings/investments. It also focuses on investing in small-sized and medium-sized private companies rather than large public companies. The fund typically invests across all industry sectors, with a particular expertise in the energy and industrial sectors. It invests in aerospace and defense, chemicals, conglomerate services, consumer services, ecological, electronics, financial services, machinery, manufacturing, media, pharmaceuticals, retail, software, specialty minerals, textiles and leather, transportation, oil and gas production, coal production, materials, industrials, consumer discretionary, information technology, utilities, pipeline, storage, power generation and distribution, renewable and clean energy, oilfield services, healthcare, food and beverage, education, business services, and other select sectors. It prefers to invest in the United States and Canada. The fund seeks to invest between $10 million to $500 million per transaction in companies with EBITDA between $5 million and $150 million, sales value between $25 million and $500 million, and enterprise value between $5 million and $1000 million. It fund also co-invests for larger deals. The fund seeks control acquisitions by providing multiple levels of the capital structure. The fund focuses on sole, agented, club, or syndicated deals.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
